Cardiovascular Evaluation of Etrasimod, a Selective Sphingosine 1‐phosphate Receptor Modulator, in Healthy Adults: Results of a Randomized, Thorough QT/QTc Study

Ähnliche Einträge

• Thorough QT Study on the Effect of Therapeutic and Supratherapeutic Dosing of Givinostat in Healthy Volunteers
  von: Eugenio Mercuri, et al.
  Veröffentlicht: (2026)
• Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults
  von: Caroline A. Lee, et al.
  Veröffentlicht: (2024)
• Lack of Concentration‐QTc Relationship and Cardiac Risk With Vatiquinone Therapeutic and Supratherapeutic Doses
  von: Lucy Lee, et al.
  Veröffentlicht: (2024)
• Pacritinib Impact on QT Interval: Results of a Thorough QT Study and Post Hoc Analysis of Prospective Clinical Trial Data
  von: Sarah A. Buckley, et al.
  Veröffentlicht: (2026)
• A Randomized Thorough QT Trial Using Concentration‐QT Analysis to Evaluate the Effects of Centanafadine on Cardiac Repolarization
  von: Osman S. Turkoglu, et al.
  Veröffentlicht: (2025)